Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

HIV/AIDS Clinical Trials Network Laboratory Centers

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute of Allergy and Infectious Diseases is seeking applications for up to four Laboratory Centers to support Clinical Trials Networks focused on ending the HIV epidemic. These centers will provide the necessary laboratory structure and technologies to test prevention and treatment strategies and conduct implementation research. The selected centers will be responsible for overseeing site-affiliated laboratories, ensuring protocol-specified testing, maintaining sample integrity from collection to storage, and utilizing advanced data management and tracking systems. The Laboratory Centers will be tasked with selecting and approving qualified laboratories and promoting state-of-the-art assays to increase testing capacity for HIV and related diseases. This opportunity is issued by the National Institutes of Health under the Department of Health and Human Services, operating under the authority of the Public Health Service Act and applicable federal regulations.

General Info

NIAID seeks up to four Laboratory Centers to support HIV clinical trials and advanced testing.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

621511 - Medical Laboratories

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health
Office AddressUSA
Contacts
Division of AIDS
contact@example.gov

Full Description

Show more

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting four Clinical Trials Networks (CTNs) each comprised of a Leadership and Operations Center, Statistical and Data Management Center, and Laboratory Center (LC) working with Clinical Trials Units, to test prevention and treatment strategies and conduct implementation research designed to end the HIV epidemic. This NOFO will solicit applications for up to four LCs that will provide laboratory structure and technologies to one or more CTNs and conduct laboratory testing for Network trials, according to regulatory standards. The LC oversees site-affiliated clinical and specialized laboratories and ensures protocol-specified laboratory testing.  The LC will: 1) support sample integrity from collection to final testing/storage; 2) use appropriate laboratory data capturing management and tracking systems; 3) select, determine readiness, and approve laboratories; and 4) promote state-of-the-art laboratory assays. The LC will increase testing capacity to meet advances in prevention and treatment of HIV and HIV-related diseases.


Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.

Similar Contracts

Same NAICS industry code

NAICS: 621511
New
SLED
Pathology Services - Zoo
Solicitation # 2027-0044
The City of El Paso is soliciting bids under solicitation number 2027-0044 for pathology services, specifically to support the Zoo. The contract will be a single award for all items, provided on an as-needed basis for biopsies and necropsies. The initial performance period is three years, with an option for two additional one-year extensions at the same unit pricing. The annual budgeted amount for these services is 600.00 dollars. Standard shipping, freight, and handling charges must be included in the bid price, while expedited shipping costs will be treated as pass-through expenses at the provider's actual net cost. The solicitation process began with a release on September 29, 2026, with bids due by October 28, 2026, at 2:00 P.M. MST. A contract award is approximately expected in January 2027. To be considered responsive, bidders must submit a complete bid form, a signed bid submittal page, a Form W-9, and several critical affidavits, including a Non-Collusion and Business Disclosure Affidavit, an Indebtedness Affidavit, and a Texas Disclosure of Interested Parties (Form 1295). Bidders must also certify compliance with Texas Government Code regarding non-discrimination against firearm entities and confirm they are not currently debarred or suspended from government transactions.
City Of El Paso

POSTED

about 18 hours ago

DEADLINE

in 28 days
View Details
NAICS: 621511
New
Federal
MAMC Newborn Screening Services
Solicitation # HT941026QE047
The Defense Health Agency Contracting Activity Healthcare Contracting Division West intends to award a sole-source, firm-fixed-price Indefinite Delivery Indefinite Quantity contract to the Washington State Department of Health for newborn screening services. This procurement, identified by solicitation number HT941026QE047, is designated for the Madigan Army Medical Center Labor and Delivery unit at Joint Base Lewis McChord, Washington, which handles approximately 1,200 newborns annually. The scope of work includes the collection of blood specimens via heel drops within 48 hours of birth, testing for phenylketonuria and other heritable or metabolic disorders, and reporting the results. All samples must be received by the department of health within 72 hours of collection. The contract has an estimated ceiling of 1,500,000 dollars with an anticipated ordering period of five years. This is a sole-source procurement under the statutory authority of 41 U.S.C. 1901 and FAR 12.102-1 Simplified Acquisition Procedures, as Washington State Statute RCW 70.83.020 designates the Washington State Department of Health as the only authorized entity to administer these services. Price reasonableness will be determined based on the legislatively set prices for entities contracting with the State of Washington. While this is a notice of intent and not a request for quotes, interested parties capable of meeting the statutory requirements may submit documentation of their capabilities by October 16, 2026.
Defense Health Agency Hcd West

POSTED

about 23 hours ago

DEADLINE

in 16 days
View Details
NAICS: 621511
New
Federal
Q301--VISN 22 Semen & Vasectomy Test Kits
Solicitation # 36C26226Q1411_1
Solicitation 36C26226Q1411 is a request for a single-award, firm-fixed-price Blanket Purchase Agreement to provide a comprehensive one-stop shop for Semen Analysis and Post Vasectomy Semen Analysis testing for the Department of Veterans Affairs VISN 22 healthcare centers. The contractor is responsible for providing FDA registered prepackaged mail-in kits for home self-collection, managing all logistics, and performing laboratory testing. The requirement includes the provision of all necessary supplies, such as temperature-controlled packaging with seasonal gel packs and non-toxic preservatives, ensuring specimens remain stable for at least 48 hours. The contract structure consists of a base year and four optional years, with annual estimated quantities of 1,104 Full Semen Analysis kits and 636 Post Vasectomy Semen Analysis kits. Notably, the contractor must provide up to two repeat PVSA tests at no additional cost. This procurement is a total small business set-aside under NAICS 62151//621511. The performing laboratory must maintain CLIA certification, although the previous requirement for CAP accreditation has been removed via amendment. Compliance with HIPAA, OSHA bloodborne pathogen standards, and DOT hazardous materials regulations for infectious substances is mandatory. Award will be granted to the responsible offeror who is technically acceptable and provides the lowest price. Following several amendments, the final response deadline for offers is September 18, 2026, at 07:00 Pacific Time.
262-NETWORK Contract Office 22 (36C262)

POSTED

about 23 hours ago

DEADLINE

in 2 days
View Details
NAICS: 621511
New
Federal
Q301--New Reference Lab Testing | Legacy VISN 15
Solicitation # 36C25526R0066
The Department of Veterans Affairs, Veterans Integrated Services Network (VISN) 15, is seeking a contractor to provide comprehensive reference laboratory testing services for clinical and anatomical pathology specimens. The scope of work includes pre-analytic processing, analytical testing, result interpretation, and reporting, as well as the transportation of specimens from various VA Medical Centers and Health Care Centers across Missouri, Kansas, and Illinois. The contractor is responsible for providing all necessary personnel, equipment, facilities, and supplies, including specimen collection materials, containers, and dry ice. All testing must be performed within the United States at facilities accredited by the College of American Pathologists or The Joint Commission and certified under the Clinical Laboratory Improvement Act of 1988. The contract will be managed through individual task orders for each participating location, with the potential for additional sites to be added via bilateral modification. Key requirements include strict adherence to HIPAA and other federal confidentiality statutes, compliance with OSHA and DOT regulations for the transport of hazardous biological substances, and the implementation of secure, encrypted IT interfaces for data transmission. Performance will be monitored by the Contracting Officer's Representative through the tracking of turnaround times and specimen integrity, with a specific quality threshold of fewer than three lost specimens per quarter. Invoices are to be submitted monthly in arrears to the VA Financial Service Center following approval by the assigned COR.
255-NETWORK Contract Office 15 (36C255)

POSTED

about 23 hours ago

DEADLINE

in 14 days
View Details
NAICS: 621511
New
SLED
(Sole Source) National Medical Services TOX_DI (MA)
Solicitation # SRC0000036155
This sole source solicitation, number SRC0000036155, is for a National Medical Service Annual Master Agreement to provide laboratory testing services for specimens submitted by the Toxicology and Death Investigation sections of the Alabama Department of Forensic Sciences. The service period is scheduled from October 1, 2026, through September 30, 2027, with all return items to be sent to the Birmingham Lab in Hoover, Alabama. The agency will award the purchase order based on available budget constraints and may conduct pricing analysis based on cost realism or price reasonableness. The contract is governed by the State of Alabama Quick Quote Standard Boilerplate, which limits the total contract cost to 25,000 dollars or a total time period of five years, including any annual renewals. Suppliers must be registered in Alabama Buys and submit responses electronically. Mandatory requirements include compliance with the Beason-Hammon Alabama Taxpayer and Citizen Protection Act via E-Verify and certification of Alabama state and local tax compliance. The State reserves the right to request professional licenses, certificates of insurance, and manufacturer authorizations after bid opening. Payment will be issued through electronic methods such as EFT or state-issued credit cards, and the contract remains subject to the appropriation of funds.
Birmingham TOX

POSTED

1 day ago

DEADLINE

in 1 day
View Details
NAICS: 621511
New
Federal
Drug and Alcohol Surveillance TestingThis subcontract for the Department of Justice involves providing drug and alcohol surveillance testing for prime contractors operating within Bureau of Prisons Residential Reentry Center projects. The selected provider will be responsible for conducting urinalysis and alcohol testing in strict accordance with P.S. 6060, P.S. 6590, and Attachment G to identify illegal substances, with a requirement to deliver all test results and surveillance reports. The project is categorized under NAICS code 621511 and will be performed in Sacramento. Interested parties must submit their responses by October 28, 2026, following the posting date of September 28, 2026.
Residential Reentry - Co

POSTED

2 days ago

DEADLINE

in 28 days
View Details
NAICS: 621511
New
Federal
Drug and Alcohol Testing ServicesThis subcontract for Drug and Alcohol Testing Services supports prime contractors on Federal Bureau of Prisons Residential Reentry Center and Home Confinement projects under the Department of Justice. The selected provider will be responsible for performing random drug and alcohol surveillance, collecting specimens via urinalysis, conducting narcotic identification, and executing site visits for testing. All services must be delivered by certified drug testing collectors and performed within a CLIA accredited laboratory to ensure the delivery of verified test results and surveillance reports. The project is categorized under NAICS code 621511 and is slated for performance in Springfield. Interested parties must submit their responses by the deadline of October 28, 2026.
Residential Reentry - Co

POSTED

2 days ago

DEADLINE

in 28 days
View Details
NAICS: 621511
New
Grant
Biomarker & Multi-Tissue Analysis ServicesThis subcontract for Biomarker and Multi-Tissue Analysis Services supports prime contractors on NIH HEAL Initiative projects under the Department of Health and Human Services. The primary objective is to provide specialized laboratory analysis to identify and validate biological mechanisms across various tissues, utilizing high-resolution imaging and mass spectrometry to perform molecular assays. The selected provider will deliver quantitative data regarding joint pathophysiology, along with validated mechanistic data and comprehensive laboratory reports. This opportunity, categorized under NAICS code 621511, was posted on September 28, 2026, with a response deadline of October 30, 2026.
National Institutes Of Health

POSTED

2 days ago

DEADLINE

in 30 days
View Details
NAICS: 621511
New
SLED
Drug and Alcohol Specimen Collection ServicesThis subcontract for Drug and Alcohol Specimen Collection Services involves performing urine and blood sample collections for prime contractors supporting the Hidalgo County Sheriff’s Office employee testing projects. Certified staff are responsible for conducting the collection program, managing secure chain-of-custody materials, and ensuring all processes comply with local, state, and federal drug testing regulations to deliver biological samples ready for laboratory analysis. The opportunity is categorized under NAICS code 621511 and is associated with the Texas Sheriff’s Department. The solicitation was posted on September 26, 2026, with a response deadline of October 14, 2026.
Sheriff’s Department

POSTED

4 days ago

DEADLINE

in 14 days
View Details
NAICS: 621511
New
SLED
Drug & Alcohol Testing Services
Solicitation # RFB-26-0512-10-14-04
Hidalgo County is soliciting bids under RFB-26-0512-10-14-04 for the provision of drug and alcohol testing services for the Sheriff's Department. The selected contractor will manage a collection program on an as-needed basis, performing urine, blood, and breathalyzer tests for pre-employment, return-to-duty, and post-accident scenarios. A key requirement includes conducting random unannounced testing for approximately 25 percent of employees licensed by the Texas Commission on Law Enforcement and those in safety-sensitive positions on a semiannual or as-needed basis. All services must be performed by certified personnel, including Medical Review Officers, Breath Alcohol Technicians, and Substance Abuse Professionals, in accordance with U.S. Department of Transportation standards and county protocols. The contract is intended for an initial two-year term with the option for three additional one-year extensions. Award decisions will be based on a combination of price, performance, and compliance, with a preference for the lowest and best qualification. Bidders must adhere to strict regulatory requirements, including HIPAA compliance, Title VI nondiscrimination, and the Texas Prompt Payment Act. Submission of responses is required by October 14, 2026, at 3:00 pm CST, via electronic portal or hand delivery. Required documentation includes insurance certificates, HUB declarations, non-collusion affidavits, and certifications regarding debarment and suspension.
Sheriff’s Department

POSTED

4 days ago

DEADLINE

in 14 days
View Details
NAICS: 621511
New
Federal
IA OJS MMU-Forensic ServicesThe Department of the Interior's Bureau of Indian Affairs Office of Justice Services Missing and Murdered Unit is seeking forensic services to support DNA identification, evidence processing, DNA profiling, and genetic genealogy to generate investigative leads. These services will be provided on an as-needed basis across the entire United States to support cases within the Missing and Murdered Unit. This forecast is designated as a total small business set-aside under NAICS code 621511. The contract is estimated at 500,000 dollars per year for a total duration of five years, consisting of a base year and four option years.

POSTED

5 days ago

DEADLINE

N/A
View Details
NAICS: 621511
New
Grant
Biospecimen Collection & Biorepository ManagementThis subcontract with the National Institutes of Health under the Department of Health and Human Services focuses on the collection and management of longitudinal biospecimens to support prime contractors on research projects. The primary objective is to deliver a curated and cataloged biorepository by establishing specimen set guidelines, managing Signature Cohorts, and utilizing LIMS for sample tracking. Operations must be conducted within BSL-2 laboratory standards and maintain strict HIPAA compliance. The infrastructure requires the use of liquid nitrogen storage and ultra-low temperature freezers to ensure specimen integrity. This effort falls under NAICS code 621511 and is scheduled for a response deadline of November 5, 2029.
National Institutes Of Health

POSTED

5 days ago

DEADLINE

in about 3 years
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

New
Grant
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 513130
New
Grant
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications for the NLM Grants for Scholarly Works in Biomedicine and Health program. This initiative provides funding for the creation of book-length manuscripts and other integrative scholarly works, such as critical reviews and analytical syntheses, designed to benefit U.S. health professionals, scientists, and public health practitioners. The primary goal is to organize and disseminate biomedical and health-related knowledge to improve research, education, and clinical practice. This opportunity is listed as a forecast with a posted date of September 24, 2026. It specifically prohibits the use of clinical trials. Interested parties can contact the NLM Extramural Programs office for further information regarding the application process and program requirements.
Book Publishers

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
Partnerships for Advancing Development of Diagnostics for Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is seeking to establish partnerships between academic or small business investigators and industrial partners to advance the translational development of diagnostic tests for infectious diseases. This initiative focuses on moving diagnostics that have already demonstrated proof-of-concept through the commercialization process by aligning researchers with experienced industry partners to de-risk development and ensure products are fit for purpose. The program will be supported by a science advisory board and NIAID oversight, incorporating annual meetings and workshops to facilitate collaboration and knowledge exchange. This effort is authorized under the Public Health Service Act and federal regulations to ensure that promising diagnostic technologies are successfully translated into tools for treating and preventing infectious diseases.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)The National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This initiative aims to bridge the gap between traditional clinical trial findings and real-world application by supporting collaborations on effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The program focuses on the prevention and treatment of HIV, including associated coinfections and comorbidities, across all age groups and various points of care. The goal of the program is to advance cross-cutting research in epidemiology, implementation science, and clinical, behavioral, and social sciences. This effort aligns with the broader NIH mission to implement research advances in HIV/AIDS. The opportunity is authorized under the Public Health Service Act and relevant federal regulations, with administrative oversight provided by the Division of AIDS Epidemiology Branch.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
New
Grant
Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)The National Institutes of Health, under the Department of Health and Human Services, is seeking applications to establish a national network of Children's Environmental Health Research Translation Centers. These centers are designed to protect and improve children's health by developing scientific questions and public health interventions focused on translational research. A primary objective is to move evidence-informed biomedical findings into practical application for the wider community while mentoring a new generation of investigators in the field. Beyond research and translation, the program will function as a national resource to coordinate responses to emerging environmental exposures that impact children. The initiative emphasizes the creation of actionable strategies to prevent harm and ensure a healthy future for children through collaborative efforts within the environmental health community.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
The Role of the Innate Immune System in the Pathogenesis of Type 1 DiabetesThe National Institute of Allergy and Infectious Diseases, under the Department of Health and Human Services, is forecasting a grant opportunity to investigate the role of the innate immune system in the initiation of Type 1 Diabetes. Funded by the Special Statutory Funding Program for Type 1 Diabetes Research, this initiative seeks to identify genetic and environmental causes of the disease by examining how innate immune components interact with beta cells and pancreatic tissues. The program emphasizes the use of new approach methodologies to determine the timing and impact of environmental triggers that activate these immune pathways. The primary objective is to improve the early identification of high-risk individuals and develop future prevention and therapeutic strategies. This effort is conducted under the authority of the Public Health Service Act and relevant federal regulations. Interested parties can contact the RISP-T1D point of contact for further information regarding this forecast.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)The National Institute of Neurological Disorders and Stroke (NINDS) is seeking to support scientific research using data from intermediate-size patient population expanded access protocols for Amyotrophic Lateral Sclerosis (ALS). To be eligible, protocols must provide access to an investigational drug or biological product for individuals with ALS and generate data that supports research into the prevention, diagnosis, mitigation, treatment, or cure of the disease. Research goals may include analyzing the effects of products on biomarkers, target engagement, safety and outcome information such as survival and hospitalization, or general patient experience data. This opportunity is currently listed as a forecast by the National Institutes of Health under the Department of Health and Human Services, and applications are not being solicited at this time. The notice serves as a preliminary announcement to allow potential applicants sufficient time to develop responsive projects. Interested parties can contact the ALS Program for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

7 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesThe National Institute of Neurological Disorders and Stroke, in collaboration with other NIH entities, is forecasting support for research projects aimed at enhancing biomedical and behavioral rigor, replicability, and reproducibility. Key areas of interest include assessing the scientific impact of these improvements, creating frameworks for selecting high-value replication studies, and measuring the robustness and generalizability of research findings to drive scientific innovation. This notice serves as a forecast to allow potential applicants to establish collaborations and develop responsive projects, as formal applications are not currently being solicited. Interested parties can contact the NINDS Office of Research Quality for further information.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

8 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)The National Institutes of Health, through the National Institute of Mental Health, is issuing a forecast for a Notice of Funding Opportunity titled Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs). This initiative aims to establish a research network to evaluate the clinical effectiveness, safety, and durability of rapid-acting treatments such as ketamine, esketamine, and psilocybin for individuals with serious mental illnesses. The primary objective is to generate actionable real-world evidence to determine how these interventions can be safely and sustainably integrated into routine clinical practice across diverse patient populations and healthcare settings. By addressing current gaps in knowledge regarding implementation and long-term benefits, the project seeks to inform future healthcare delivery strategies for emerging psychotropic treatments.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

14 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Emerging Global Leader Award (K43)The Emerging Global Leader Award (K43), issued by the National Institutes of Health under the Department of Health and Human Services, provides salary and research support to junior faculty and research scientists based at academic or research institutions in Low- and Middle-Income Countries. The program focuses on biomedical, behavioral, and clinical research that leverages unique opportunities in these regions to create generalizable knowledge benefiting both U.S. and international populations. Recipients must engage in intensive mentored research and career development guided by senior researchers from both the U.S. and their respective home countries. By leveraging existing NIH research investments, the initiative aims to develop global research leaders who can mentor future investigators and strengthen international research networks.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

14 days ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS